Industry Trends

Sunny Kumar, MD, partner at GSR Ventures speaks about how healthcare and clinical trials can work together to create a greater impact at the SCOPE 2023 conference in Orlando, FL.

Len Rosenberg, head of clinical operations at Beat AML, reveals how changing the backbone treatment to a different regimen is beneficial to the patient, in terms of the safety with the same efficacy.

Len Rosenberg, head of clinical operations at Beat AML, comments on how factors, such as proper data collection and reporting techniques, can prove to be efficient and help save lives.

Sunny Kumar, MD, partner at GSR Ventures speaks about areas of investment in clinical trials at the SCOPE 2023 conference in Orlando, FL.

Murray L. Aitken, SVP of IQVIA speaks about the requirements of small biopharma clinical development at the SCOPE 2023 conference in Orlando, FL.

Murray L. Aitken, SVP of IQVIA speaks about how biopharma companies can take advantage of present opportunities at the SCOPE 2023 conference in Orlando, FL.

SCOPE session discusses key challenges of evaluating potential providers.

Panel at SCOPE discusses applying novel evidence in regulatory decision-making.

Panel at SCOPE discusses the possibilities of research in a post-COVID world.

Seagen, an oncology biotech, emphasizes personalization as part of its DE&I strategy.

DCTs and RWD among topics for industry to focus on moving into 2023.

Strong shift to DCTs, regulatory changes, and increased focus on diversity among main industry talking points in 2022.

Industry must act now to minimize effects of COVID-19 on clinical research.

With large shift to decentralized strategies, industry roles appear set for change.

Pandemic sparks new long-term plan for success in R&D.

Data, patient recruitment, and regulators all highlighted in these three predictions for the new year.

Insights from Syneos Health’s 2022 Health Trends: Insights for Industry Change Agent.

Top predictions for the major trends that will shape clinical trial design in 2022.

What the industry’s most inspiring technology innovators see coming in 2022.

The full potential of artificial intelligence is still yet to be realized.

Findings from Florence Healthcare’s State of Clinical Trial Technology Industry survey about how clinical operations technology changed in 2020 and how they expected it to evolve throughout this year.

Lessons from six months of conducting clinical trials during the COVID-19 pandemic

The perfect storm of industry growth, opportunity, and demand is translating to solid salary and satisfaction levels among clinical trial professionals, according to new survey.

Dealmaking spurt and key upcoming regulatory guidances point the trajectory ahead in clinical research space.

Weighing overall workplace trends in the life sciences with new survey findings and views on job satisfaction.

Most physicians and many specialists have limited understanding of clinical trial data and research findings presented in prescription drug promotional materials for professional audiences.

Peter O'Donnell discusses Brexit challenges and how the life sciences industry is affected.

The European generic drug industry homed in on the opportunity to “help the EU and member states develop effective policies that support access to medicines for patients.”

The EU’s national health organizations are contemplating to abandon their highly-prized autonomy, and forge common positions and buying strategies for accessing expensive new drugs.